Artivion (AORT) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.93% |
| Dec 31, 2025 | 29.12% |
| Sep 30, 2025 | 23.72% |
| Jun 30, 2025 | 45.05% |
| Mar 31, 2025 | -53.18% |
| Dec 31, 2024 | 57.09% |
| Sep 30, 2024 | -2.29% |
| Jun 30, 2024 | 52.41% |
| Mar 31, 2024 | -46.43% |
| Dec 31, 2023 | 0.60% |
| Sep 30, 2023 | -2.76% |
| Jun 30, 2023 | 55.21% |
| Mar 31, 2023 | 8.75% |
| Dec 31, 2022 | -15.28% |
| Sep 30, 2022 | 7.23% |
| Jun 30, 2022 | -35.10% |
| Mar 31, 2022 | -16.59% |
| Dec 31, 2021 | -32.33% |
| Sep 30, 2021 | -18.42% |
| Jun 30, 2021 | -9.78% |
| Mar 31, 2021 | -32.96% |
| Dec 31, 2020 | 30.96% |
| Sep 30, 2020 | 9.70% |
| Jun 30, 2020 | -23.49% |
| Mar 31, 2020 | 15.21% |
| Dec 31, 2019 | -26.03% |
| Sep 30, 2019 | 38.71% |
| Jun 30, 2019 | -23.61% |
| Mar 31, 2019 | 20.77% |
| Dec 31, 2018 | 14.00% |
| Sep 30, 2018 | 2.73% |
| Jun 30, 2018 | -31.81% |
| Mar 31, 2018 | -52.77% |
| Dec 31, 2017 | -5.62% |
| Sep 30, 2017 | -14.34% |
| Jun 30, 2017 | -20.98% |
| Mar 31, 2017 | 16.47% |
| Dec 31, 2016 | 10.63% |
| Sep 30, 2016 | 8.73% |
| Jun 30, 2016 | 1.92% |
| Mar 31, 2016 | -18.27% |
| Dec 31, 2015 | -27.40% |
| Sep 30, 2015 | 5.02% |